These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 20980993

  • 1. A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice.
    Urs NM, Daigle TL, Caron MG.
    Neuropsychopharmacology; 2011 Feb; 36(3):551-8. PubMed ID: 20980993
    [Abstract] [Full Text] [Related]

  • 2. Loss of β-arrestin2 in D2 cells alters neuronal excitability in the nucleus accumbens and behavioral responses to psychostimulants and opioids.
    Porter-Stransky KA, Petko AK, Karne SL, Liles LC, Urs NM, Caron MG, Paladini CA, Weinshenker D.
    Addict Biol; 2020 Nov; 25(6):e12823. PubMed ID: 31441201
    [Abstract] [Full Text] [Related]

  • 3. Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice.
    Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, Caron MG.
    J Neurosci; 2003 Nov 12; 23(32):10265-73. PubMed ID: 14614085
    [Abstract] [Full Text] [Related]

  • 4. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward.
    Borgkvist A, Usiello A, Greengard P, Fisone G.
    Neuropsychopharmacology; 2007 Sep 12; 32(9):1995-2003. PubMed ID: 17251906
    [Abstract] [Full Text] [Related]

  • 5. Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.
    Daigle TL, Wetsel WC, Caron MG.
    Eur J Neurosci; 2011 Nov 12; 34(9):1378-89. PubMed ID: 22034973
    [Abstract] [Full Text] [Related]

  • 6. The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine.
    Marquez P, Borse J, Nguyen AT, Hamid A, Lutfy K.
    Neuroscience; 2008 Aug 26; 155(3):597-602. PubMed ID: 18634857
    [Abstract] [Full Text] [Related]

  • 7. Fear Memory Recall Potentiates Opiate Reward Sensitivity through Dissociable Dopamine D1 versus D4 Receptor-Dependent Memory Mechanisms in the Prefrontal Cortex.
    Jing Li J, Szkudlarek H, Renard J, Hudson R, Rushlow W, Laviolette SR.
    J Neurosci; 2018 May 09; 38(19):4543-4555. PubMed ID: 29686048
    [Abstract] [Full Text] [Related]

  • 8. Cocaine-Dependent Acquisition of Locomotor Sensitization and Conditioned Place Preference Requires D1 Dopaminergic Signaling through a Cyclic AMP, NCS-Rapgef2, ERK, and Egr-1/Zif268 Pathway.
    Jiang SZ, Sweat S, Dahlke SP, Loane K, Drossel G, Xu W, Tejeda HA, Gerfen CR, Eiden LE.
    J Neurosci; 2021 Jan 27; 41(4):711-725. PubMed ID: 33268547
    [Abstract] [Full Text] [Related]

  • 9. Evidence that behavioral phenotypes of morphine in β-arr2-/- mice are due to the unmasking of JNK signaling.
    Mittal N, Tan M, Egbuta O, Desai N, Crawford C, Xie CW, Evans C, Walwyn W.
    Neuropsychopharmacology; 2012 Jul 27; 37(8):1953-62. PubMed ID: 22491351
    [Abstract] [Full Text] [Related]

  • 10. Morphine prevents lipopolysaccharide-induced TNF secretion in mast cells blocking IκB kinase activation and SNAP-23 phosphorylation: correlation with the formation of a β-arrestin/TRAF6 complex.
    Madera-Salcedo IK, Cruz SL, Gonzalez-Espinosa C.
    J Immunol; 2013 Sep 15; 191(6):3400-9. PubMed ID: 23960234
    [Abstract] [Full Text] [Related]

  • 11. Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery.
    Bohn LM, Dykstra LA, Lefkowitz RJ, Caron MG, Barak LS.
    Mol Pharmacol; 2004 Jul 15; 66(1):106-12. PubMed ID: 15213301
    [Abstract] [Full Text] [Related]

  • 12. Loss of BDNF signaling in D1R-expressing NAc neurons enhances morphine reward by reducing GABA inhibition.
    Koo JW, Lobo MK, Chaudhury D, Labonté B, Friedman A, Heller E, Peña CJ, Han MH, Nestler EJ.
    Neuropsychopharmacology; 2014 Oct 15; 39(11):2646-53. PubMed ID: 24853771
    [Abstract] [Full Text] [Related]

  • 13. Genetic reconstruction of dopamine D1 receptor signaling in the nucleus accumbens facilitates natural and drug reward responses.
    Gore BB, Zweifel LS.
    J Neurosci; 2013 May 15; 33(20):8640-9. PubMed ID: 23678109
    [Abstract] [Full Text] [Related]

  • 14. Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models.
    Su Y, Raghuwanshi SK, Yu Y, Nanney LB, Richardson RM, Richmond A.
    J Immunol; 2005 Oct 15; 175(8):5396-402. PubMed ID: 16210646
    [Abstract] [Full Text] [Related]

  • 15. Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone.
    Quillinan N, Lau EK, Virk M, von Zastrow M, Williams JT.
    J Neurosci; 2011 Mar 23; 31(12):4434-43. PubMed ID: 21430144
    [Abstract] [Full Text] [Related]

  • 16. Termination of protease-activated receptor-1 signaling by beta-arrestins is independent of receptor phosphorylation.
    Chen CH, Paing MM, Trejo J.
    J Biol Chem; 2004 Mar 12; 279(11):10020-31. PubMed ID: 14699102
    [Abstract] [Full Text] [Related]

  • 17. Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization.
    Karlsson RM, Hefner KR, Sibley DR, Holmes A.
    Psychopharmacology (Berl); 2008 Sep 12; 200(1):117-27. PubMed ID: 18600316
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol.
    Valjent E, Bertran-Gonzalez J, Aubier B, Greengard P, Hervé D, Girault JA.
    Neuropsychopharmacology; 2010 Jan 12; 35(2):401-15. PubMed ID: 19759531
    [Abstract] [Full Text] [Related]

  • 19. Galanin protects against behavioral and neurochemical correlates of opiate reward.
    Hawes JJ, Brunzell DH, Narasimhaiah R, Langel U, Wynick D, Picciotto MR.
    Neuropsychopharmacology; 2008 Jul 12; 33(8):1864-73. PubMed ID: 17957220
    [Abstract] [Full Text] [Related]

  • 20. RGS9-2 is a negative modulator of mu-opioid receptor function.
    Psifogeorgou K, Papakosta P, Russo SJ, Neve RL, Kardassis D, Gold SJ, Zachariou V.
    J Neurochem; 2007 Oct 12; 103(2):617-25. PubMed ID: 17725581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.